drugset / Trial / NCT01811355
Mexiletine for the Treatment of Muscle Cramps in ALS
Phase 4
Completed
23 enrolled
Bjorn Oskarsson, MD
ALS Association · collabUniversity of California, Davis · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine if mexiletine is effective for the treatment of muscle cramps in Amyotrophic Lateral Sclerosis (ALS).
Timeline
- Start
- 2013-05
- Primary completion
- 2016-03
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mexiletine | Small molecule | 150 mg | Oral |